Back to top

Athersys (ATHX) in Focus: Stock Moves 6.8% Higher
December 16, 2013

Read MoreHide Full Article
Athersys, Inc. (ATHX - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up 13.4% over the past one month time frame.

The company has seen a mixed track record when it comes to estimate revisions, of one increase and one decrease over the past one month, while the Zacks Consensus Estimate has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Athersys currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better ranked med-biomed/gene stocks include Actelion Ltd. , Neuralstem, Inc. and GeoVax Labs, Inc. . While Actelion and Geovax Labs hold a Zacks Rank #1 (Strong Buy), Neuralstem carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Athersys, Inc. (ATHX) - free report >>

More from Zacks Tale of the Tape

You May Like